A drug-resistant fungal ‘superbug’ has infected people across 23 U.S. states
A drug-resistant fungal ‘superbug’ has infected people across 23 U.S. states.
Experts say it is spreading unchecked in healthcare facilities.
The Centers for Disease Control and Prevention (CDC) has recorded over 3,130 screening cases of Candida auris, a highly resilient yeast that can cause severe, sometimes fatal infections in seriously ill patients.
While healthy individuals face a low risk of becoming ill, those requiring complex medical treatments with catheters, breathing tubes, or feeding tubes are highly susceptible.
The major danger of Candida auris lies in its ability to silently ‘colonize’ patients—remaining on their skin or body sites without causing immediate symptoms—while easily spreading onto bedrails, shared medical equipment, and furniture to infect others.
Compounding the crisis is the superbug’s alarming resistance to standard treatments. Although most cases can still be managed with specific antifungal drugs, some strains have developed resistance to all three major classes of antifungal medications, making them extremely difficult to cure.
Health authorities emphasize that preventing transmission is vital; healthcare facilities must enforce strict hand hygiene, use specialized disinfectants, and carefully screen patients. Because patients can remain colonized long after treatment, families and providers are urged to maintain open communication and rigorous infection-control precautions to halt the fungus’s invisible spread.
source: Mills, D. (2026). Candida Auris: Drug-Resistant ‘Superbug’ Spreading in 23 States, CDC Says. Healthline.
